Eton Pharmaceuticals, Inc.
ETON
$16.90
-$2.24-11.70%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
11/8/2025
-
Tickeron - Stocks
11/8/2025
-
Tickeron - Stocks
11/8/2025
-
TipRanks Financial Blog
11/7/2025
-
Tickeron - Technical Analysis
11/7/2025
-
MarketBeat
11/7/2025
-
GuruFocus
11/7/2025
-
Seeking Alpha: Transcripts
11/7/2025
-
SeekingAlpha
11/7/2025
-
GuruFocus
11/6/2025
-
Zacks Investment Research
11/6/2025
-
GuruFocus
11/6/2025
-
GuruFocus
11/6/2025
-
Globe Newswire
Eton Pharmaceuticals (ETON, $19.25) price may drop as it broke higher Bollinger Band on Nov 05, 2025
11/6/2025
-
Tickeron - Stocks
11/5/2025
-
GuruFocus
11/3/2025
-
MarketBeat
11/3/2025
-
Ticker Report
11/3/2025
-
MarketBeat
10/29/2025
-
Tickeron - Stocks
10/26/2025
-
MarketBeat
10/25/2025
-
SeekingAlpha
10/23/2025
-
GuruFocus
10/23/2025
-
Globe Newswire
10/14/2025
-
ETF Channel
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 6, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 16 and 20 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
847 787 7361
Address
21925 W. Field Parkway
Deer Park, IL 60010-7278
Deer Park, IL 60010-7278
Country
Year Founded
Business Description
Sector
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the...
more